Common Peptide Impurities: Deletion Sequences, Oxidation, and Aggregation

A number without a story

A purity figure tells you how much impurity is present but nothing about what it is or where it came from. That absence matters, because two lots at the same purity can carry entirely different impurity profiles with different consequences for stability, comparability, and interpretation of any downstream work. Controlling impurities begins with naming them.

Most of the impurities in a synthetic peptide fall into a few recurring families, each traceable to a specific step. Understanding those origins turns an anonymous cluster of small peaks into a diagnostic map — one that points back at the process and forward at how the material should be handled.

Deletion sequences: the arithmetic of imperfect coupling

Solid-phase synthesis builds a peptide one residue at a time, and no coupling step is perfectly efficient. When a residue fails to add on a fraction of the growing chains, those chains continue without it, producing a molecule missing one amino acid — a deletion sequence. Because each step contributes its own small failure rate, deletions accumulate with sequence length, which is why longer peptides are inherently harder to make clean.

Deletion sequences are the archetypal process-related impurity: intrinsic to synthesis rather than to storage. They differ from the target by the mass of the missing residue and often elute close to the main peak, forming the familiar shoulder-and-cluster pattern near the principal peak on a chromatogram. Related truncated and insertion sequences share the same origin in imperfect chain assembly.

Because they are so close in structure to the target, these impurities are among the hardest to remove in purification and among the hardest to resolve analytically. A deletion missing a small residue can differ from the parent by a mass so slight, and a hydrophobicity so similar, that it barely separates on a reverse-phase method. That closeness is exactly why they reward orthogonal characterization rather than trust in a single clean-looking peak.

• Coupling efficiency compounds over every step, so failure probability rises with chain length.
• Deletions differ from the target by one residue’s mass, which mass spectrometry can often resolve.
• Their structural closeness to the parent makes them difficult to remove and to separate chromatographically.

Oxidation: damage that arrives after synthesis

Oxidation is a degradation route, not a synthesis error, and it targets specific residues. Methionine is the classic case, oxidizing readily to its sulfoxide, and cysteine, tryptophan, and histidine are also vulnerable. The literature on methionine oxidation documents both how easily it occurs and how it can sometimes be reversed enzymatically in biological contexts, underscoring that it is a chemically distinct, characterizable change.

Because oxidation adds oxygen, it shifts mass in small, recognizable increments and typically produces a peak eluting near the parent. It can occur during synthesis and workup but often develops in storage, driven by exposure to air, light, and moisture. That distinction is practical: an oxidation impurity that grows over time is telling you something about handling, not only about manufacture.

Aggregation: molecules that find each other

Aggregation is a physical process in which peptide molecules associate into dimers, higher oligomers, or larger assemblies. It is driven by concentration, sequence, solution conditions, and stress, and for many peptides it is the dominant physical-stability concern. Reviews of peptide aggregation describe how sequence and formulation factors govern the tendency and how it complicates both analysis and storage.

Aggregates behave differently from small-molecule impurities. They may not resolve on a reverse-phase method tuned for monomeric species, so a purity chromatogram can look clean while aggregates go uncounted. Detecting them often calls for orthogonal techniques — size-based separations chief among them — which is a reminder that the method defines what "pure" means.

Detectability: the impurities your method cannot see

Not every impurity is visible to every method, and that is the crux of impurity control. A reverse-phase HPLC method with UV detection sees species that separate under its conditions and absorb at its wavelength. Impurities that co-elute with the main peak, absorb weakly, or fall below the reporting threshold are simply not counted, no matter how careful the integration.

This is why a single method rarely constitutes a control strategy. Mass spectrometry can distinguish species that share a retention time, size-based methods reveal aggregates a reverse-phase run misses, and specialized methods address specific residue chemistries. The published guidance on synthetic peptide quality attributes, USP 1503 among it, frames impurity characterization as a multi-method endeavor for exactly this reason.

• Co-eluting impurities can hide under the principal peak of a single HPLC method.
• Aggregates often require size-based separation rather than reverse-phase HPLC.
• Mass spectrometry resolves same-retention-time species that chromatography alone cannot.

Why the identity of an impurity matters

It is tempting to treat all impurities as interchangeable and manage them with a single total limit. Regulatory and pharmacopeial thinking rejects that shortcut, because impurities differ in significance. Identifying and, where warranted, characterizing individual impurities is a recognized expectation for peptide quality, and the growing literature on peptide impurity immunogenicity illustrates why the identity — not just the amount — can carry weight.

For a buyer or a bench scientist, identity translates into interpretation. An impurity known to be a deletion sequence carries a different implication than an unidentified peak, and an oxidation product that grows across storage points to a handling problem rather than a manufacturing one. A profile with named impurities is far more actionable than a lone total number.

Building a control strategy

A control strategy links each impurity family to the step that creates it and the method that catches it. Deletion sequences are addressed at synthesis and purification and monitored chromatographically. Oxidation is limited by controlling exposure during processing and storage and tracked by methods sensitive to the mass shift. Aggregation is managed through formulation and handling and confirmed with size-based analysis.

The unifying principle is that control follows origin. Because process impurities and degradation impurities arise at different points, they are prevented in different ways, and a strategy that treats them uniformly will over-invest in one while missing another. Individual acceptance criteria for the impurities that matter, backed by methods that can see them, is what makes a specification meaningful rather than decorative.

Process impurities versus degradation impurities

The single most useful sorting rule is when the impurity was born. Process-related impurities — deletion sequences, insertions, incomplete deprotection — are present the moment the material is made and do not grow afterward. Degradation impurities such as oxidation and aggregation may be low at release and increase over time. The two categories call for different responses even when they appear at similar levels on a chromatogram.

This distinction reshapes what a purity number tells you. A given percentage made up of stable process impurities behaves predictably in storage; the same percentage dominated by degradation species may worsen. Without knowing which is which, a buyer cannot tell whether a profile is stable or a starting point for further decline, which is another argument for identifying impurities rather than only totaling them.

Storage is part of the profile

An impurity profile is a snapshot, not a permanent property. Oxidation and aggregation can both progress after release, so the profile at manufacture may not describe the material months later under poor conditions. Cold, dry, dark, well-sealed storage slows the degradation routes that otherwise turn a clean release profile into a compromised one.

That temporal dimension is why handling belongs in any honest discussion of impurities. The best synthesis and the tightest release specification do not protect material that is stored carelessly. Knowing which impurities grow — and why — lets a user preserve the quality that was paid for.